Avinger receives FDA approval for enhanced OCT image-guided atherectomy system

Avinger (Redwood City, CA) has received FDA clearance for an enhanced version of the company's Pantheris lumivascular atherectomy system, an optical coherence tomography (OCT) image-guided atherectomy device for treating periphery artery disease (PAD). The company will begin marketing this enhanced version of Pantheris immediately, which features improved ergonomics, physician controls, and manufacturability.

Related: FDA-approved device sees inside occluded arteries causing PAD

Atherectomy is a minimally invasive treatment for PAD in which a catheter-based device is used to remove plaque from a blood vessel. Lumivascular technology utilized in the Pantheris system allows physicians to see from inside the artery during a directional atherectomy procedure by using OCT. In the past, physicians have had to rely solely on x-ray as well as touch and feel to guide their tools while they try to treat complicated arterial disease. With the lumivascular approach, physicians can more accurately navigate their devices and treat PAD lesions, thanks to the OCT images they see from inside the artery.

In the recently completed VISION study, 130 patients were treated with Pantheris and followed for a period of six months. The study achieved its primary safety and efficacy endpoints, and showed a target lesion revascularization rate of 8%. No single event of vessel perforation, clinically significant dissection, or late aneurysm resulted from using the system.

In October 2015, the company received FDA clearance for the Pantheris system for treating patients with PAD, and subsequently filed a second 510(k) application in December 2015 seeking clearance for the enhanced version of the system.

For more information, please visit www.avinger.com.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.

Optical Coherence Tomography: Beyond better clinical care: OCT's economic impact

The optical coherence tomography (OCT) industry has grown dramatically in its first 25 years.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World